Justin Frantz

Justin Frantz currently serves as the Head of Investor Relations at Keros Therapeutics, a position held since May 2023. Prior to this role, Justin Frantz spent over two years at Solebury Trout, where responsibilities included roles as Senior Associate and Associate from May 2021 to June 2023.